Incidence trends of vulvar squamous cell carcinoma in Italy from 1990 to 2015.


Journal

Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304

Informations de publication

Date de publication:
06 2020
Historique:
received: 16 12 2019
accepted: 08 03 2020
pubmed: 11 4 2020
medline: 14 1 2021
entrez: 11 4 2020
Statut: ppublish

Résumé

The incidence of vulvar squamous cell carcinoma has increased for decades in most Western countries - a trend virtually restricted to women aged <50 or 60 years. In southern Europe, conversely, the trends have been insufficiently studied. This article reports a study from Italy. Thirty-eight local cancer registries, currently covering 15,274,070 women, equivalent to 49.2% of the Italian national female population, participated. Invasive cancers registered between 1990 and 2015 with an International Classification of Diseases for Oncology, 3rd revision, topography code C51 and morphology codes compatible with vulvar squamous cell carcinoma (n = 6294) were eligible. Incidence trends were analysed using joinpoint regression models, with calculation of the estimated annual percent change (EAPC), and age-period-cohort models. Total incidence showed a regular and significant decreasing trend (EAPC, -0.96; 95% confidence interval (CI), -1.43 to -0.48). This was entirely accounted for by women aged ≥60 years (EAPC, -1.34; 95% CI, -1.86 to -0.81). For younger women, the EAPC between 1990 and 2012 was 1.20 (95% CI, 0.34 to 2.06) with a non-significant acceleration thereafter. This pattern did not vary substantially in a sensitivity analysis for the effect of geographic area and duration of the registry. The age-period-cohort analysis revealed a risk decrease in cohorts born between 1905 and 1940 and a new increase in cohorts born since 1945. The decreasing trend observed among older women and the resulting decrease in total rate are at variance with reports from most Western countries. Age-period-cohort analysis confirmed a decreasing trend for earliest birth cohorts and an opposite one for recent ones.

Identifiants

pubmed: 32273199
pii: S0090-8258(20)30229-8
doi: 10.1016/j.ygyno.2020.03.013
pii:
doi:

Types de publication

Historical Article Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-663

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interest.

Auteurs

Silvia Mancini (S)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.

Lauro Bucchi (L)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.

Flavia Baldacchini (F)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.

Orietta Giuliani (O)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.

Alessandra Ravaioli (A)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy. Electronic address: alessandra.ravaioli@irst.emr.it.

Rosa Vattiato (R)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy.

Mario Preti (M)

Department of Obstetrics and Gynaecology, University of Torino, Torino, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy.

Stefano Ferretti (S)

University of Ferrara, Local Health Authority, Ferrara, Italy.

Annibale Biggeri (A)

Department of Statistics, Computer Science, Applications G. Parenti, University of Florence, Florence, Italy.

Angelita Brustolin (A)

Unit of Epidemiology and Cancer Registry, Local Health Authority, Viterbo, Italy.

Lorenza Boschetti (L)

Pavia Cancer Registry, Public Health Agency of Pavia, Pavia, Italy.

Anna L Caiazzo (AL)

Cancer Registry of Local Health Authority Salerno, Salerno, Italy.

Adele Caldarella (A)

Tuscany Cancer Registry, Clinical and Descriptive Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Rosaria Cesaraccio (R)

Sassari Cancer Registry, Azienda Regionale per la Tutela della Salute - ATS, Sassari, Italy.

Claudia Cirilli (C)

Modena Cancer Registry, Public Health Department, Local Health Authority, Modena, Italy.

Annarita Citarella (A)

Cancer Registry, Department of Prevention, Unit of Epidemiology, Local Health Authority, Benevento, Italy.

Rosa A Filiberti (RA)

Liguria Cancer Registry, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Mario Fusco (M)

Napoli 3 Sud Cancer Registry, Napoli, Italy.

Rocco Galasso (R)

Unit of Regional Cancer Registry, Clinical Epidemiology and Biostatistics, IRCCS-CROB, Basilicata, Rionero in Vulture, Italy.

Luciana Gatti (L)

Mantova Cancer Registry, Epidemiology Unit, Agenzia di Tutela della Salute (ATS) della Val Padana, Mantova, Italy.

Fernanda L Lotti (FL)

Brindisi Cancer Registry, Local Health Authority, Brindisi, Italy.

Michele Magoni (M)

Cancer Registry of Brescia Province, Epidemiology Unit, Brescia Health Protection Agency, Brescia, Italy.

Lucia Mangone (L)

Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy.

Giuseppe Masanotti (G)

Section of Public Health and RTUP Register, Department of Experimental Medicine, University of Perugia, Perugia, Italy.

Guido Mazzoleni (G)

South-Tyrol Tumor Registry, Bolzano, Italy.

Walter Mazzucco (W)

Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.

Anna Melcarne (A)

Lecce Province Cancer Registry, Lecce, Italy.

Maria Michiara (M)

Parma Cancer Registry, Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

Paola Pesce (P)

Catania, Messina, and Enna Cancer Registry, Catania, Italy.

Silvano Piffer (S)

Trento Province Cancer Registry, Unit of Clinical Epidemiology, Trento, Italy.

Angela Pinto (A)

Barletta, Andria, Trani Cancer Registry, BAT Province, Barletta, Italy.

Magda Rognoni (M)

Epidemiology Unit, Cancer Registry of ATS Brianza, Health Protection Agency, Monza, Italy.

Stefano Rosso (S)

Piedmont Cancer Registry, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.

Massimo Rugge (M)

Veneto Tumour Registry, Azienda Zero, University of Padova-DIMED, Padova, Italy.

Giuseppe Sampietro (G)

Bergamo Cancer Registry, ATS Bergamo, Bergamo, Italy.

Santo Scalzi (S)

Catanzaro ASP Cancer Registry, Catanzaro, Italy.

Tiziana Scuderi (T)

Trapani and Agrigento Cancer Registry, Trapani, Italy.

Giovanna Tagliabue (G)

Lombardy Cancer Registry-Varese Province, Cancer Registry Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Francesco Tisano (F)

Cancer Registry of the Province of Siracusa, Siracusa, Italy.

Federica Toffolutti (F)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Susanna Vitarelli (S)

Macerata Province Cancer Registry, University of Camerino, Camerino, Italy.

Fabio Falcini (F)

Romagna Cancer Registry, Romagna Cancer Institute, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì, Italy; Cancer Prevention Unit, Local Health Authority, Forlì, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH